companydata.dkcompanydata.dk

LGC Biosearch Technologies A/S: Financial statements 2022

CVR: 34884900

Source: annual report 2022, Danish Business Authority

01/04/2021 – 31/03/2022

LGC Biosearch Technologies A/S (CVR 34884900) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 101,481,096 and a net result of DKK 12,605,086 compared with DKK 35,594,712 the year before. That is a decrease of 2.2% compared with the year before. The profit margin was 12.4%. Equity in the 2022 report amounted to DKK 65,580,999. The solvency ratio was 74.9%. The company had 22 employees in the financial year.

Revenue
DKK 101,481,096
Gross Profit
DKK 50,542,258
Profit/Loss
DKK 12,605,086
Equity
DKK 65,580,999
Total Assets
DKK 87,575,427
Employees
22

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022101.5M50.5M12.6M65.6M22
2021103.8M70.9M35.6M53M29
202041.8M23.2M8M17.4M22
2019-15.8M3.8M9.3M19
2018-10.5M-2M5.6M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on LGC Biosearch Technologies A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Lucas-Caspar Schwinner-Strachwitz joins the board of LGC Biosearch Technologies A/SOct 11, 2022

As of October 11, 2022, Lucas-Caspar Schwinner-Strachwitz has joined the board of directors of LGC Biosearch Technologies A/S.

Ross Frazer Finlay leaves the board of LGC Biosearch Technologies A/SOct 11, 2022

As of October 11, 2022, Ross Frazer Finlay has left the board of directors of LGC Biosearch Technologies A/S.

About LGC Biosearch Technologies A/S

LGC Biosearch Technologies A/S is a Danish company of the type Aktieselskab based in Lystrup, founded in 2012. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named DNA TECHNOLOGY A/S and BIOSEARCH TECHNOLOGIES DENMARK A/S. The management consists of Daren Dick. The board consists of Henrik Daugård (chair), Bettina Kecskes and Daren Dick. The company is owned by Biosearch Technologies, Inc.. The company has 47 employees (2026). In 2026, the company reported revenue of DKK 106,677,751 and a net result of DKK 8,198,725 compared with DKK 11,805,577 the year before. Equity in the 2026 report amounted to DKK 88,072,722.

Source: annual report 2026, Danish Business Authority